EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS091-14237 
Organism
Homo sapiens 
Tissue/cell
HepG2 
Coordinate
chr14:104210680-104212700 
Target genes
Number: 4             
NameEnsembl ID
TF binding sites/motifs
Number: 3             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
LMX1BMA0703.2chr14:104212453-104212464GTTTTAATTAA+6.14
Nr2f6(var.2)MA0728.1chr14:104212361-104212376TGAACTCCTGACCTC-6.22
ZNF263MA0528.1chr14:104212630-104212651CCCACCCCCCGCCCCTCCACC-6.28
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_08167chr14:104210684-104212323Brain_Inferior_Temporal_Lobe
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr14104211176104211226
Number: 1             
IDChromosomeStartEnd
GH14I103745chr14104211901104212050
Enhancer Sequence
AACAAAAAAC CCTCCAAAAC AAAACCCGCG CTACGCCAGC ATCTGTCCCT TGGTGTCACA 60
CTCTTTCTAA GGATGGGAGG GTACACGTGG CCCCACCCAG ACTCCATACC TGTCTGTTGA 120
AGAAAGGGAC AAATTACGTT TGTGTGGCAT CTTTTTCAAA TCTAGATGTG ATGAGCAGAC 180
CTTTGTCAGT TTGGAAAAAC AAGTGACAGG TGATTTTGTA CATATTAAAG AGGACGCAGC 240
TTCCCACTAA GCTTGTCAGC CAACATACGG TTTACAAATG GGCTTGCAGA GGGCCGCGAG 300
GAGCCATAAT TAGGCCCGAC GTCGAGGTCT GACACTGTCC ATGAGCTGGT CACTCTGGGT 360
TTACTGTGGC CATCTGTGTG ACACAGAACC AGGACAGCCA ACAGCAAGGG ATTAGAGTCC 420
CTGCCAGGAG GCTTCACAGC CCAGCTCCAC CTCTGGGCTG AGCTGCTGCC CCGACTCTGA 480
AGGTGAGCAC AGGTTCCCCG TGTCCATGAC TTTCATCCAC AGCAGAGGCT AGGACCAGGG 540
CTTCGTGAAG GCATCTCCTT GCTGCAACCC CTTGAGGCAG CACAGCAGAC ACCAACAAGG 600
ACGGGACACA GGAGACATTT CTCACCTTGG GGAGTTTCTC AAAGGAAGTC AGCAGAGAAG 660
TAGCTGGCTG TGCTAATTAC CTCCCACTGG AAACAGACAA ATATCTACTC CTACCACAGG 720
GTGGTTCAAA CTATAAATAA CAGCTTAGCA GAGCAACCTG CAGTTAGGGG TTCATGCCAA 780
CCCCACACTT TATGTGGCTG CTGAGACACG GCCGTAAGGG ATCTGAGTGG GGGCTTGTGG 840
CTCACAAGTG CTGGTGATGC TCTTCTCTTT CGGAGTTCAT AACAAGACCC AAGCTCCCCA 900
GTGGGGGCAA CAGATGTGTC GCTGTCCCTC CTGGGGGCCA GGCAAGAGAA AATGAAGCAA 960
ACAAAGATGA GCACAAATCC ACCACAATCC CGAAAAAGGG GCTCGAAACA CAGGCCTGAT 1020
GGCCAGAGAG TAACAGTACT GTTTTCATAA ACGAAGGAAT GTTTCAATAC ATCAGGACAG 1080
GGATTCCTGA TGCTGTGTGT TTCAGGGAAA TGTGTCAACC TCAGTCATAA AGAAAGTCTT 1140
ATTGCAAGGA AGCCCCAACA CTTTTAATGC ACTGGTTGAG AAACAGACTC TCCATGAACA 1200
GCTTGCCCTC TGCTTGGCAG GGGCACCACC CATGGACTAC ACTAGAGGTC CAAGTCCATC 1260
ACACAGCACC ATTGTGAGGT CAAGACCAAA CCAACGATGT GTGGACTTTG ATCAATGAGG 1320
ACAGAGCGCT GTTTGTAGGG GCAGCCCCTC CACTTGGCTG GCTGTAGCCG AGTTGTGGTG 1380
AGGCATCCAT GCCGGGCCTC AGTGTCCTCA GAGTAAATAA ACCTGCAGTA AGAGAGGACA 1440
CTCGTGGGTC AGTTTTTTTT GTTTTGTTTT GTTTTGTTTT TTTTGAGATG AAGTTTCACT 1500
CTTGTTGCCC AGGCTGAAGC ACAGTGGCAC GATCTCACTG CAACCTCCGC CTCCCAGGTT 1560
CAAGTGATTC TCCCGCTTCA GCCTCCTGAG TAGCTGGGAT TACAGGTGCA CGCCACCACG 1620
CCCGGCTAAT TTTCGTAGTT TTAGTAAAGA CAGGGTTTCA CCATGTTGGC CAGGCTGGTC 1680
TTGAACTCCT GACCTCAGGT GATCCACCCG CCTTGGCCTC CCAAAGTGCT GGGATTACAG 1740
GCGTGAGCCA CTGCACCCGG CCCATGGATC AGAGTTTTAA TTAATCATTT GTGTTTTGAA 1800
AAGCCACACA GTAGAGACCT CTAGTTCAGT AAAAATAACT TGTTTTCCTT TTAGGATTGT 1860
TACCACAGGG GAACACAGCT CTCCAAGCGC CTCACGGGGA GACTGAGCCT GGAGTCTGAC 1920
GATGTGTGGG GCAGAGCCTC AGGAGCCTGC CCCACCCCCC GCCCCTCCAC CGCAGGCCCC 1980
ATTCCCTGCT CACAAACTCT CCCCCAGGAA GAGGGCCAGG 2020